Skip to main content

Table 4 The relative abundance of level 2 KEGG pathway of milk microbiota from different treatments

From: Impact of yeast and lactic acid bacteria on mastitis and milk microbiota composition of dairy cows

ItemsTreatmentsSEMP-value
HMM + YM + LM + Y + L
Human disease       
 Cancers0.1133b0.0850b0.1012b0.1456a0.1052b0.01490.024
 Immune system diseases0.0519b0.0629a0.0475b0.0541b0.0529b0.00340.012
 Infectious diseases0.4914a0.5046a0.5477a0.3779b0.4942a0.05420.092
 Metabolic diseases0.0812b0.0956a0.0824b0.0874b0.0892b0.00390.028
 Neurodegenerative diseases0.2609a0.1935b0.2158b0.2304a0.2048b0.01930.049
Organismal systems       
 Digestive system0.0567b0.0400c0.0470bc0.0767a0.0391c0.00690.002
 Environmental adaptation0.1018b0.0960b0.0992b0.1194a0.1028b0.00520.010
 Immune system0.0361b0.0363b0.0259b0.0628a0.0341b0.00910.022
Metabolism       
 Biosynthesis of other secondary metabolites0.7393b0.7458b0.6535b1.0859a0.7434b0.11510.029
 Enzyme families1.8068b1.8567a1.8796a1.8767a1.8676a0.02290.055
Environmental information processing       
 Signal transduction1.7126b1.7509b1.8880a1.6072c1.8691a0.05030.001
Cellular process       
 Signaling molecules and Interaction0.1751bc0.1972ab0.1576c0.2010a0.1682c0.01300.031
 Transport and catabolism0.3127b0.2578b0.2635b0.3818a0.2611b0.03190.013
  1. 13 level 2 KEGG pathway of milk microbiota are influenced by treatments, which are classified into 5 classfications according to the pathway involved in
  2. abcMeans in the same row with significant difference (P < 0.05)